Participants 108 145 6
patients with gastrointestinal cancer
Participants 384 455 6
leucocyte-depleted (LD) blood in patients with gastrointestinal cancer.
Participants 703 818 8
5-year survival and cancer recurrence among 512 patients with gastrointestinal cancer included in the TACTIC study.
Participants 827 1005 5
Some 89.2 per cent of patients had a primary tumour and 79.7 per cent underwent surgery with curative intent; 243 patients received perioperative RBC transfusion (median 3 units)
Participants 1007 1176 3
The 5-year overall survival rate of patients with any type of gastrointestinal cancer was 50.8 per cent in the LD group and 45.8 per cent in the non-LD group (P = 0.191)
Participants 1435 1472 4
patients with gastrointestinal cancer
